Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Three primary cancers in different organs.

F F Holmes, P A Cole

    Oncology
    |January 11, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Patients diagnosed with three primary cancers showed shorter intervals between diagnoses and death. This suggests compromised host defenses may increase cancer risk in these individuals.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Correction to: Three‑dimensional topography of scapular nutrient foramina.

    Surgical and radiologic anatomy : SRA·2020
    Same author

    Three-dimensional topography of scapular nutrient foramina.

    Surgical and radiologic anatomy : SRA·2020
    Same author

    LSD1 Histone Demethylase Assays and Inhibition.

    Methods in enzymology·2016
    Same author

    Ghrelin.

    Molecular metabolism·2015
    Same author

    The epigenetic regulators CBP and p300 facilitate leukemogenesis and represent therapeutic targets in acute myeloid leukemia.

    Oncogene·2015
    Same author

    Supracondylar osteotomy for the treatment of cubitus varus in children: a systematic review.

    The bone & joint journal·2014
    Same journal

    SF3A3 in Liver Hepatocellular Carcinoma: Oncogenic Role and Prognostic Significance.

    Oncology·2026
    Same journal

    Letter to the Editor.

    Oncology·2026
    Same journal

    FLAG-Based Versus Standard 7+3 Induction Therapy in Adults with Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis.

    Oncology·2026
    Same journal

    Longitudinal Changes in Body Weight and Body Mass Index in Patients with Chronic-Phase Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors: A Retrospective Observational Study.

    Oncology·2026
    Same journal

    Rising lung cancer burden attributable to high fasting plasma glucose in women aged ≥50 years: age-, SDI-, and BRICS-specific patterns from GBD 1990-2021.

    Oncology·2026
    Same journal

    Diagnostic Pathways and Outcomes of First-Line Atezolizumab plus Bevacizumab in Patients with Locoregional Therapy-Ineligible Hepatocellular Carcinoma at Initial Diagnosis.

    Oncology·2026
    See all related articles

    Area of Science:

    • Oncology
    • Immunology

    Background:

    • Multiple primary cancers in different organs are rare but clinically significant.
    • Understanding the factors contributing to multiple primary cancers is crucial for patient outcomes.

    Purpose of the Study:

    • To investigate the clinical characteristics and potential underlying mechanisms of patients with three primary cancers.
    • To evaluate the association between multiple primary cancers and host defense mechanisms.

    Main Methods:

    • Retrospective analysis of a cancer registry.
    • Identification of patients with three distinct primary cancers.
    • Analysis of time intervals between diagnoses, cancer staging, and survival.

    Main Results:

    • Fifteen patients out of 24,105 had three primary cancers.

    Related Experiment Videos

  • Shorter time intervals were observed between sequential cancer diagnoses and death.
  • Cancer progression was more advanced in second and third primary cancers compared to the first.
  • The occurrence and sequence of cancer sites appeared random.

    • Conclusions:

    • The findings support the hypothesis of compromised host defenses in patients developing multiple primary cancers.
    • Further research into immune surveillance and cancer development is warranted.